RE:RE:RE:RE:RE:Takeover talksAre you trying to bait me here with this "Takeover Talks" thread? The idea of a buyout at $70 / share at this time not only strikes an aporetic chord with me, it is outright laughable. Now I recognize that I am fairly naive and gullible, and I may even be convinced that aliens control our share price (LOL),
but I do not believe that there is a takeover happening now. AMCo was a relatively unknown UK firm before Concordia bought it and there is limited recent financial data on regulatory financial portals for any takeover. Even the most rabid acquirer will want a show and tell for a few quarterss. Especially now with our big brother now up in flames the landscape for M&A has changed course for spec pharma. No? Yes?
And if anyone is thinking an activist takeover there was a press release back in October 2015 advising of an Adoption of Advance Notice By Law. So that means no chance of a hostile takeover either. Sorry to diappoint you.
Roller007 wrote: Deathpool: that's why the sale price will have to be a low one. I'm guessing in the 70 Canadian range which is a far cry from where it's at now. Many investors dropped their average price to below that figure and would approve the sale in my opinion.